Stockreport

Ekso Bionics Announces $3.7 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules

Ekso Bionics Holdings, Inc.  (EKSO) 
NASDAQ:AMEX Investor Relations: ir.eksobionics.com
PDF SAN RAFAEL, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (the “Company”) (Nasdaq: EKSO), a leading developer of exoskeletons for medical and i [Read more]